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Abstract
Introduction—Community-based and other epidemiologic studies within the United States have 
identified substantial disparities in health care among adults with epilepsy. However, few data 
analyses addressing their health-care access are representative of the entire United States. This 
study aimed to examine national survey data about adults with epilepsy and to identify barriers to 
their health care.
Materials and methods—We analyzed data from U.S. adults in the 2010 and the 2013 National 
Health Interview Surveys, multistage probability samples with supplemental questions on epilepsy. 
We defined active epilepsy as a history of physician-diagnosed epilepsy either currently under 
treatment or accompanied by seizures during the preceding year. We employed SAS-callable 
SUDAAN software to obtain weighted estimates of population proportions and rate ratios (RRs) 
adjusted for sex, age, and race/ethnicity.
Results—Compared to adults reporting no history of epilepsy, adults reporting active epilepsy 
were significantly more likely to be insured under Medicaid (RR = 3.58) and less likely to have 
private health insurance (RR = 0.58). Adults with active epilepsy were also less likely to be 
employed (RR = 0.53) and much more likely to report being disabled (RR = 6.14). They 
experience greater barriers to health-care access including an inability to afford medication (RR = 
2.40), mental health care (RR = 3.23), eyeglasses (RR = 2.36), or dental care (RR = 1.98) and are 
more likely to report transportation as a barrier to health care (RR = 5.28).
Conclusions—These reported substantial disparities in, and barriers to, access to health care for 
adults with active epilepsy are amenable to intervention.
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The Institute of Medicine has recently affirmed the paramount importance of quality health-
care access for people with epilepsy and has identified deficiencies therein [1]. At nearly the 
same time, the U.S. Department of Health and Human Services published new public health 
objectives, Healthy People 2020, for the first time listing among its priorities the 
improvement of access to appropriate epilepsy care [2]. Several sources provide evidence 
that many people with epilepsy in the United States currently lack such care. Community-
based and other epidemiologic studies within the United States have identified substantial 
disparities in health care among people with epilepsy: variable quality and timeliness of 
evaluations following the onset of the disorder, variable qualifications among physicians 
providing principal care for epilepsy, variable use of newer medications with fewer side 
effects, and varying extents to which patients with treatment-resistant epilepsy are referred 
to specialty centers that have advanced diagnostic and treatment resources [1,3–5]. These 
disparities are manifest especially among people of different socioeconomic strata, race, and 
locality — characteristics which are, of course, closely interrelated in the United States 
[3,6].
Few data addressing health-care access among people with epilepsy have been analyzed that 
are representative of the United States as a whole. One analysis of data from a 2005 survey 
conducted in 13 states examined epilepsy prevalence and access to specialty care [7]. More 
recently, we reported preliminary data on epilepsy from the 2010 National Health Interview 
Survey (NHIS) [8]. People with active epilepsy represented 1.0% of the U.S. civilian 
noninstitutionalized population aged 18 years or more but comprised a disproportionately 
higher percentage (1.9%) of those in households of low income (less than $35,000 annually). 
A salient finding of that study was the unexpectedly low proportion (52.8%) of those with 
active epilepsy who reported seeing a neurologist or epilepsy specialist during the past year.
The purpose of this study was to examine the 2010 and 2013 NHIS data pertaining to people 
with epilepsy in greater depth, to identify barriers to their health care, and to assess these 
findings in the context of other relevant studies.
2. Materials and methods
The National Health Interview Survey is an annual cross-sectional household interview 
survey using a multistage area probability sampling design intended to represent the civilian 
noninstitutionalized U.S. population [9]. In 2010 and 2013, the interviewed samples for the 
Sample Adult component were 27,157 and 34,557 adults 18 years of age and older, 
respectively, 98.6% of whom provided direct self-reported answers to questions; for the 
remainder, answers were provided by knowledgeable proxies [10]. In these two years, the 
survey included supplemental questions on epilepsy. A screening question asked whether a 
doctor or other health professional had ever diagnosed the person with epilepsy or a seizure 
disorder. For those with affirmative responses, follow-up questions asked whether they were 
currently taking medication to control the condition, whether they had one or more seizures 
in the past year, and whether they had seen a neurologist or epilepsy specialist in the past 
year [7].
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For this report, as in the preceding report [8], we defined active epilepsy as a history of 
physician-diagnosed epilepsy that was either currently under treatment with medication or 
was accompanied by seizures during the year preceding the survey. In the 2010 and 2013 
NHIS, 1066 adult respondents reported a history of physician-diagnosed epilepsy, 644 
(59%) of whom were classified as active epilepsy. Mental health needs of the survey 
recipients were assessed based on responses to 6 items of the Kessler Screening Scale for 
Psychological Distress (K6), which assesses symptom severity for feelings during the past 
30 days described as ‘sad’, ‘nervous’, ‘restless or fidgety’, ‘hopeless’, ‘everything is an 
effort’, and ‘worthless’ [11]. A total K6 symptom severity score of 13 or more, summed 
across 6 items scored from 0 to 4, indicates serious psychological distress. The K6 is an 
efficient screen for “serious mental illness” in the general population [12]. Other 
standardized 2010 and 2013 NHIS questions on type of health insurance coverage, access to 
a primary care physician, vision care, dental care, mental health care, barriers to care, and 
sociodemographic questions examined in this study are available at: http://www.cdc.gov/
nchs/nhis/nhis_questionnaires.htm.
We employed SAS® (version 9.3)-callable SUDAAN® (version 11) statistical software to 
account for the complex survey design, using stratification, clustering, and weighting to 
obtain estimates of population proportions and rate ratios (RRs) adjusted for age, sex, and 
race/ ethnicity with 95% confidence intervals (CIs). We used the SUDAAN MULTILOG 
procedure for two-group comparisons [13]. We examined relative standard errors (RSEs) to 
judge reliability of estimates. Where the estimates are less than 50%, the RSE is the standard 
error divided by the estimate and then multiplied by 100 to obtain a percent. Where the 
estimates are ≥50%, the RSE is the standard error of the estimate / [(100% – value of the 
estimate)] * 100. Relative standard errors ≥ 30% were considered unreliable. Only more 
reliable estimates with RSEs < 30% are presented in the tables.
3. Findings
The estimated number of adults having active epilepsy constituted 0.99% [95% CI: 0.90%–
1.09%] of the U.S. adult population. Of this estimated number, 17% [14%–21%] were aged 
65 years or older.
3.1. Comparisons between persons with active epilepsy and without epilepsy
We first examined health insurance coverage, the preeminent determinant of access to health 
care. Table 1 shows the distribution of types of health insurance coverage among adults with 
active epilepsy and among adults with no history of epilepsy, stratified by age group. Among 
all adults with active epilepsy, 36% were covered under private health insurance, 33% under 
Medicaid, 15% under other types including Medicare, and 16% were uninsured. Compared 
to adults with no history of epilepsy, adults reporting active epilepsy were significantly more 
likely to be insured under Medicaid (RR = 3.58 [3.09–4.15]) and less likely to have private 
health insurance coverage (RR = 0.58 [0.51–0.66]). Among adults aged 18–64 years, those 
with active epilepsy were much less likely to have private health insurance (RR = 0.52 
[0.44–0.60]) and much more likely to have Medicaid (RR = 3.89 [3.35–4.52]) than those 
without epilepsy. Among adults aged ≥65 years, although those with active epilepsy were 
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twice as likely to have Medicaid as those without epilepsy (RR = 1.98 [1.34–2.91]), nearly 
all persons in both groups had some type of insurance.
Among all adults with active epilepsy, 50% saw both a primary care physician and a 
neurologist or epilepsy specialist in the 12 months preceding the survey; 36% saw only a 
primary care physician; 8% saw only a neurologist or epilepsy specialist; and 6% saw 
neither.
At the time of data collection for this study, prior to the 2014 expansions in health-care 
coverage under the Affordable Care Act [14], the system of health insurance in the United 
States was more closely tied to employment. We examined the impact of active epilepsy on 
employment status as well as insurance status (Table 1). Among all adults with active 
epilepsy, only 32% reported being employed, while 36% reported being disabled. Compared 
to adults with no history of epilepsy, those with active epilepsy were significantly less likely 
to be employed (RR = 0.53 [0.45–0.62]) and much more likely to report being disabled (RR 
= 6.14 [5.41–6.97]). Among persons aged 18–64 years, adults with active epilepsy were 
much less likely to report being employed (RR = 0.53 [0.44–0.63]) and much more likely to 
report being disabled (RR = 6.63 [5.78–7.60]) than adults with no history of epilepsy. 
Similar relationships occurred among persons aged ≥ 65 years for being disabled (RR= 2.98 
[1.96–4.55]), although only the latter was statistically significant. Among persons aged ≥65 
years, 68% of those with active epilepsy and 75% of those without epilepsy described 
themselves as retired.
Potential consequences of inadequate health insurance coverage and reduced income are 
shown in Fig. 1. Compared to adults with no history of epilepsy, adults with active epilepsy 
much more likely reported an inability to afford the cost of eyeglasses (18% among those 
with active epilepsy vs. 8% of those without, RR = 2.36 [1.92–2.90]), dental care (27% vs. 
14%, RR = 1.98 [1.69–2.33]), mental health care (8% vs. 2%, RR = 3.23 [2.29–4.54]), and 
prescription medication (21% vs. 9%, RR = 2.40 [1.99–2.89]) when these items or services 
were needed during the preceding year. Nine percent of those with active epilepsy could not 
obtain health care because they had no transportation, compared to only 2% of those without 
epilepsy (RR = 5.28 [3.93-7.09]).
Twenty-seven percent (27%) of those with active epilepsy versus 7% of those with no 
history of epilepsy reported visits for services from a mental health-care provider in the past 
year (RR = 3.62 [3.06–4.29]) (Fig. 2). Serious psychological distress during the past 30 days 
was present in 17% of those with active epilepsy, compared to 3% of those without epilepsy 
(RR = 5.09 [4.07–6.37]). Distress in the past 30 days from any of the K6 items sufficient to 
interfere with ‘life or activities’ to a degree described as “‘a lot’ or ‘some’” was present in 
30% of those with epilepsy, compared to 10% of those without (RR = 2.86 [2.44–3.34]).
3.2. Comparisons of persons with active epilepsy and with orwithout recent seizures
Fifty-eight percent [53.1%–63.3%] of those with active epilepsy reported having one or 
more seizures during the year preceding their interview. Among adults with active epilepsy, 
we compared health insurance coverage, employment status, and access to selected health 
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services between those who reported having seizures during the past year and those who did 
not.
Table 2 compares the respective distributions of health insurance and employment 
categories. Adults with active epilepsy reporting seizures in the past year were more likely 
than those reporting no seizures to report being disabled (44% vs. 34%), although this 
finding was not statistically significant after adjustment (RR = 1.28 [0.99–1.66]). Health 
insurance coverage and other employment status did not differ significantly by level of 
seizure control.
We examined potential consequences of inadequate health insurance and income barriers to 
health care among adults with active epilepsy by level of seizure control (Fig. 3). Those who 
reported recent seizures were much more likely than those without recent seizures to report 
being unable to afford eyeglasses (24% vs. 10%, RR = 2.34 [1.39–3.93]), dental care (34% 
vs. 18%, RR = 1.91 [1.27–2.88]), and prescription medication (26% vs. 13%, RR = 2.08 
[1.30–3.32]).
Thirty-nine percent (39% [95% CI: 32–46]) of those experiencing seizures in the past year 
had not seen a neurologist, compared to 46% (95% CI: 39–54) of those whose seizures were 
reportedly controlled. Those with and without recent seizures did not differ statistically in 
reported psychological distress and use of mental health services.
4. Discussion
4.1. Interpretation
An important finding of this study is the low proportion of adults with active epilepsy – only 
42% – who reported complete freedom from seizures during the year before interview. This 
finding may be considered in light of other studies indicating that with adequate care, at least 
two-thirds of patients with a current diagnosis of epilepsy can achieve complete seizure 
remission [15,16]. Also important is our finding that 38% of those who are not seizure-free 
have not seen a neurologist or epilepsy specialist in the past year, consistent with previous 
state estimates [7,17]. Together, these findings indicate a large treatment gap.
Other findings of our study add dimensions to this treatment gap. A consistent picture 
emerges, revealing very high rates of disability or unemployment among adults with 
epilepsy, consistent with substantially lower incomes, a finding in the previous analysis [8]. 
Adults with active epilepsy are somewhat (but not statistically significantly) less likely to be 
uninsured than those without epilepsy. However, adults with active epilepsy (especially 
those of working age, 18–64 years old) are less likely to have private health insurance and 
more likely instead to be covered by Medicaid. While benefits such as medications and 
specialty care access vary among private health insurance policies, such benefits appear 
more restricted on the whole with public insurance such as Medicaid and may be 
unaffordable to many who lack health insurance [18–20]. These findings deserve further 
analysis in future studies, but taking them into account, it is perhaps not surprising that a 
substantial proportion of adults with active epilepsy report being unable to afford important 
elements of health care, including medication. This might explain previous findings related 
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to medication nonadherence among adults with active epilepsy [7], problems that are 
amplified among those whose seizures are not in remission. Our findings also provide a 
more comprehensive assessment of gaps and barriers in other critical areas of health and 
daily functioning for adults with epilepsy — including challenges with dental and vision 
care. However, for some adults with epilepsy, addressing other basic needs in the context of 
social and economic disadvantages (e.g., employment, meeting other household caregivers' 
needs) may take precedence over health-care needs, underscoring the necessity for expanded 
supportive services, programs, and policies to reduce health inequities [21]. The 2010 
Affordable Care Act created an optional Medicaid State Plan benefit for states to establish 
Health Homes to coordinate care for people with Medicaid who have chronic conditions 
such as epilepsy. Health homes include a broad range of mandated services, including 
comprehensive care management, care coordination, patient and family support, and referral 
to community and social support services. States can target health home enrollment by 
condition [7]. Future studies can examine whether health homes improve outcomes in 
Medicaid recipients with epilepsy.
Among the comorbidities of epilepsy, mental health disorders are important. Our analysis 
confirms earlier findings [22] that psychological distress is substantially more prevalent 
among adults with active epilepsy, making their greater need for mental health services 
evident. The findings from this survey indicate not only that adults with active epilepsy use 
more mental health services than adults without epilepsy but also that significant numbers 
are unable to afford or find access to sufficient services. Another study among community-
dwelling adults with epilepsy in California found a large gap between perceived mental 
health need and provision of mental health care [23]. The degree to which mental health care 
needs exceed available services deserves further study.
Providing additional training about epilepsy, its comorbidities, psychosocial challenges, and 
appropriate care to primary care providers might assist them in providing more 
comprehensive care to their patients with epilepsy. Additional research is also needed to 
assess access to appropriate specialized care for other common comorbidities of epilepsy, 
the ways adults with epilepsy prioritize and manage their health problems, and the effects of 
distance from patients' residences to epilepsy and other specialized care centers. Other 
studies have identified disparities in access to health care and related problems among 
people with other chronic diseases [24–26]. Thus, such problems are not unique to people 
with epilepsy, although further research is needed to elucidate the extent to which people 
with epilepsy may be disproportionately disadvantaged, for example, with transportation 
barriers, functional neurological impairments, and stigma. Such research could lead to more 
specific policy recommendations. Noting, however, that people with chronic disorders spend 
most of their time in community settings (e.g., homes, worksites, schools, senior centers, 
faith-based organizations) versus physicians' offices, ensuring that these individuals have 
access to chronic disease self-management support is also critical in helping individuals, 
such as those with epilepsy, manage their condition [27,28].
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4.2. Strengths and limitations
This study is more broadly representative of the U.S. population than studies limited to more 
specific localities [6,7,29]. Its findings serve to complement the findings of these more 
specific studies, although this study focuses only on adults. The NHIS is a large-scale 
survey, yielding relatively many sampled cases of active epilepsy (n = 644) on which to base 
estimates. Although this large sample provides good precision of estimates for the larger 
groups we analyzed, the precision of estimates for smaller groups is reduced, including the 
adjusted estimates of relative risk.
The sources of NHIS data are self-reports which, compared to clinical sources, are likely to 
yield an increased proportion of misclassified cases. Self-reports may yield inaccuracies in 
other relevant variables as well. An indication of the magnitude of case misclassification is 
provided by a validation study of the subset of questions used to identify active epilepsy in 
the NHIS, which found a sensitivity of 81%, a specificity of 99%, and a positive predictive 
value of 74% using abstracted information from medical records as a reference standard 
[30]. The inclusion of some persons who do not have true epilepsy among the reported cases 
of epilepsy in our study is likely to bias some of our results. This bias would serve to 
underestimate differences comparing cases with noncases. Accordingly, our comparative 
estimates are likely to be conservative.
4.3. Conclusion
Epilepsy is a chronic condition often requiring lifelong medical care. As it is frequently 
difficult to manage, specialty care is important. The consequences of poorly managed 
epilepsy are severe: Recurrent seizures may result in loss of gainful employment or inability 
to work, reduced income, reduced opportunities in education, decreased social participation, 
limitations in mobility with loss of driving privileges, other decrements of quality of life, 
and an increased risk of injury, disability, and death [1]. The extent to which recent health-
care reforms in the United States, under the Affordable Care Act, may improve access to 
quality care for epilepsy and mitigate some of the findings remains to be seen. Continuing 
surveillance is warranted to assess these outcomes.
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Barriers to health care among adults with active epilepsy and without epilepsy. Notes: ‘No 
epilepsy’ indicates persons providing no history of ever having been diagnosed with epilepsy 
or seizure disorder.‘Eyeglasses’, ‘Dental care’, ‘Mental health care’, and ‘Medication’ refer 
to the percentage of respondents indicating an inability to afford these types of care when 
needed during the past year. ‘Transportation’ indicates an inability to obtain transportation to 
a site providing health care during the past year. Numbers indicate percentage point 
estimates. Error markers indicate 95% confidence limits.
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Mental health-care needs and services among adults with active epilepsy and without 
epilepsy. Notes: ‘No epilepsy’ indicates persons providing no history of ever having been 
diagnosed with epilepsy or seizure disorder. ‘Visit to MH professional’ indicates the 
proportion of persons with visits for professional mental health services within the past year. 
‘Psychological distress’ indicates the proportion of persons scoring 13 points or more on the 
Kessler 6 psychological distress scale, reflecting symptoms during the past 30 days. ‘Life 
interference’ indicates the proportion of persons reporting that any symptoms measured by 
K6 were sufficient to interfere with life or activities “a lot” or “some” in the past 30 days. 
Numbers indicate percentage point estimates. Error markers indicate 95% confidence limits.
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Barriers to health care among adults with epilepsy, with and without seizures during the 
preceding year. Notes: All persons with active epilepsy aged ≥18 years. ‘Recent seizures’ 
refers to persons with active epilepsy who report ≥1 seizure during the year prior to 
interview; ‘No recent seizures’ refers to persons with active epilepsy who report no seizures 
during the year prior to interview. Numbers indicate point estimates. Error markers indicate 
95% confidence limits.
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